Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Liver Regeneration01:24

Liver Regeneration

3.3K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.3K
Stem Cell Culture01:17

Stem Cell Culture

5.2K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

G Protein-Coupled Receptors in Cerebrovascular Diseases: Signaling Mechanisms and Therapeutic Opportunities.

International journal of molecular sciences·2026
Same author

A high-entropy gradient filler metal enables high-strength joints of Ti<sub>2</sub>AlNb and GH4169 alloys.

Materials horizons·2026
Same author

Engineered AcrIIA5 for optogenetic control of CRISPR-Cas9-based genome editing.

mLife·2026
Same author

Oncolytic adenoviruses in bladder and kidney cancers: emerging strategies and next frontiers.

Frontiers in microbiology·2025
Same author

Impact of SGLT2 Inhibitors on Tumor Development Risk in Type 2 Diabetes: A Retrospective Cohort Study.

Diabetes, metabolic syndrome and obesity : targets and therapy·2025
Same author

First-line therapies analysis in advanced/metastatic urothelial carcinoma: prognostic insights in ADCs combined therapy with propensity score analysis and RNA-Seq.

International immunopharmacology·2025

Related Experiment Video

Updated: Jul 1, 2025

Isolation of CD133+ Liver Stem Cells for Clonal Expansion
12:06

Isolation of CD133+ Liver Stem Cells for Clonal Expansion

Published on: October 10, 2011

22.4K

Bioreactor-based stem cell therapy for liver fibrosis.

Mengchao Yan1,2, Jia Yao2,3, Ye Xie2

  • 1Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou 730000, People's Republic of China.

Biofabrication
|March 5, 2024
PubMed
Summary

A novel bioreactor method using mesenchymal stem cells (MSCs) offers a promising alternative to traditional infusion for treating liver fibrosis. This cell-free approach alleviates fibrosis by delivering a therapeutic medium, avoiding infusion risks.

Keywords:
bioreactorliver fibrosismesenchymal stem cells

More Related Videos

Three-Dimensional Collagen Matrix Scaffold Implantation as a Liver Regeneration Strategy
05:20

Three-Dimensional Collagen Matrix Scaffold Implantation as a Liver Regeneration Strategy

Published on: June 29, 2021

3.1K
Robust Generation of Hepatocyte-like Cells from Human Embryonic Stem Cell Populations
05:49

Robust Generation of Hepatocyte-like Cells from Human Embryonic Stem Cell Populations

Published on: October 26, 2011

47.9K

Related Experiment Videos

Last Updated: Jul 1, 2025

Isolation of CD133+ Liver Stem Cells for Clonal Expansion
12:06

Isolation of CD133+ Liver Stem Cells for Clonal Expansion

Published on: October 10, 2011

22.4K
Three-Dimensional Collagen Matrix Scaffold Implantation as a Liver Regeneration Strategy
05:20

Three-Dimensional Collagen Matrix Scaffold Implantation as a Liver Regeneration Strategy

Published on: June 29, 2021

3.1K
Robust Generation of Hepatocyte-like Cells from Human Embryonic Stem Cell Populations
05:49

Robust Generation of Hepatocyte-like Cells from Human Embryonic Stem Cell Populations

Published on: October 26, 2011

47.9K

Area of Science:

  • Regenerative Medicine
  • Hepatology
  • Biotechnology

Background:

  • Mesenchymal stem cells (MSCs) show potential for liver fibrosis treatment.
  • Traditional MSC infusion faces challenges like phenotypic drift and embolism.
  • Next-generation therapies require maintaining MSC therapeutic properties and safety.

Purpose of the Study:

  • To develop a bioreactor-based stem cell therapy to treat liver fibrosis.
  • To create a 'cell-free' therapeutic medium derived from MSCs and hepatocytes.
  • To overcome limitations associated with direct MSC infusion.

Main Methods:

  • Inducing MSC therapeutic phenotype using liver fibrosis serum.
  • Constructing a fluid bioreactor with co-cultured hepatocytes and MSCs.
  • Generating a therapeutic medium from the bioreactor system.
  • Testing the therapeutic medium in a rat model of liver fibrosis.

Main Results:

  • The bioreactor-derived medium significantly alleviated liver fibrosis in rats.
  • Therapeutic mechanisms involved immune regulation and inhibition of hepatic stellate cell activation.
  • Hepatocyte homeostasis and liver stem cell subsets were restored.
  • The approach successfully avoided direct cell infusion and its associated risks.

Conclusions:

  • Bioreactor-based stem cell therapy is a promising strategy for liver fibrosis.
  • This 'cell-free' approach mitigates risks of traditional MSC infusion.
  • The method supports the development of advanced stem cell therapies for liver diseases.